By Country
at manufacturing sites in this country 8,572 findings drawn from 1,659 published documents. The most recent cases are below; the full set is in search.
See all Canada findingsThe guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
See every finding in this document View official source"The maintenance of records was inadequate.
See every finding in this document View official sourceThe handling of standard operating procedures for good manufacturing practices was inadequate.
See every finding in this document View official sourceThe quality control department did not undertake all of the required activities.
See every finding in this document View official sourceThe availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
See every finding in this document View official sourceThe written specifications were inadequate.
See every finding in this document View official sourceThese findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-09-04, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.
Growth stages previewSolve a quiz to start hatching
Your growth record is stored safely in this browser.
